Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002048873-25-000005
Filing Date
2025-12-22
Accepted
2025-12-22 18:03:23
Documents
1
Period of Report
2025-12-22

Document Format Files

Seq Description Document Type Size
1 form4-12222025_111219.html 4  
1 form4-12222025_111219.xml 4 4054
  Complete submission text file 0002048873-25-000005.txt   5588
Mailing Address 12 HAMMERSMITH GROVE OFFICE 205 LONDON United Kingdom W6 7AP
Business Address 12 HAMMERSMITH GROVE OFFICE 205 LONDON United Kingdom W6 7AP 44-0-20-3457 6900
Silence Therapeutics plc (Issuer) CIK: 0001479615 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SILENCE THERAPEUTICS PLC 72 HAMMERSMITH ROAD LONDON X0 W14 8TH
Business Address
Ede-Golightly James (Reporting) CIK: 0002048873 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39487 | Film No.: 251593703